RIGL · NASDAQ · Biotechnology

Rigel Pharmaceuticals (RIGL)

Commercializes specialty treatments for a blood disorder, a leukemia, and RET-fusion cancers in the US.

$48.14
After hours−0.66 (−1.36%)
At close$48.81(+3.64%)